<link rel="stylesheet" href="/res/styles.39be4579664c3a48.css">
Artículo

Biological markers for evaluating therapeutic efficacy in Chagas disease, a systematic review

Pinazo, Maria Jesús ; Thomas Carazo, María del Carmen ; Bua, Jacqueline Elena Icon; Perrone, Alina Elizabeth Icon; Schijman, Alejandro Gabriel Icon; Viotti, Rodolfo Jorge ; Ramsey, Janine ; Ribeiro, Isabela ; Sosa-estani, Sergio Alejandro Icon; López, Manuel Carlos ; Gascon, Joaquim

Otros responsables

Fecha

03/2014

Editorial

Taylor & Francis

Revista

Expert Review of Anti-infective Therapy

Título del libro

Nombre del evento

Fecha del evento

Institución organizadora

ISSN

1478-7210

eISSN

ISBN

Idioma

Inglés

Tipo del evento

Clasificación temática

Resumen

The most neglected aspects of Chagas disease (CD) have been patient care and treatment. Despite recent progress in the development of potentially improved drugs, there is no consensus among different research groups on the lack of therapeutic response markers to evaluate efficacy of newly proposed drugs early after treatment. A systematic review of current evidence regarding molecules which are potential biomarkers for therapeutic response has been conducted using quality assessment and target responses as primary criteria. The review provides a panorama of the cumulative evidence and specific needs for development of a battery of complementary biomarkers which together fulfill ideal or acceptable criteria to evaluate early responses to treatment for chronic CD. There are several marker candidates which together may fulfill acceptable criteria to indicate the efficacy of a trypanocidal treatment. Data from ongoing studies are considered essential to improve assessment of existing markers and to identify those for early follow-up of treated patients.

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc-sa